APA (7th ed.) Citation

Mohammed M. Alanazi, Ibrahim H. Eissa, Nawaf A. Alsaif, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah F. Alasmari, . . . Alaa Elwan. (2021). Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Mohammed M. Alanazi, Ibrahim H. Eissa, Nawaf A. Alsaif, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah F. Alasmari, Hussam Albassam, Hazem Elkady, and Alaa Elwan. Design, Synthesis, Docking, ADMET Studies, and Anticancer Evaluation of New 3-methylquinoxaline Derivatives as VEGFR-2 Inhibitors and Apoptosis Inducers. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Mohammed M. Alanazi, et al. Design, Synthesis, Docking, ADMET Studies, and Anticancer Evaluation of New 3-methylquinoxaline Derivatives as VEGFR-2 Inhibitors and Apoptosis Inducers. Taylor & Francis Group, 2021.